Cerus Corporation Announces Significant Presence At International Blood Safety Conference; INTERCEPT Pathogen Inactivation System The Subject of 20 Scientific Presentations And A Satellite Symposium Featuring Prominent World Blood Safety Experts

CONCORD, Calif.--(BUSINESS WIRE)--Aug. 30, 2006--Cerus Corporation (NASDAQ:CERS) today announced that the company’s INTERCEPT Blood System will be featured at the annual congress of the International Society of Blood Transfusion (ISBT) being held in Cape Town, South Africa, from September 2nd through 7th.